Pre-existing immunity modulates responses to mRNA boosters

被引：20

作者：

Dangi, Tanushree ^{[1
]}

Sanchez, Sarah ^{[1
]}

Lew, Min Han ^{[1
]}

Awakoaiye, Bakare

Visvabharathy, Lavanya ^{[2
]}

Richner, Justin M. ^{[3
]}

Koralnik, Igor J. ^{[2
]}

Penaloza-MacMaster, Pablo ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA

[2] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA

[3] Univ Illinois, Dept Microbiol & Immunol, Coll Med, Chicago, IL 60612 USA

来源：

CELL REPORTS | 2023年 / 42卷 / 03期

关键词：

T-CELLS; VACCINE; EFFICACY; ANTIBODIES; CAPACITY;

D O I：

10.1016/j.celrep.2023.112167

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

mRNA vaccines are effective in preventing severe COVID-19, but breakthrough infections, emerging variants, and waning immunity warrant the use of boosters. Although mRNA boosters are being implemented, the extent to which pre-existing immunity influences the efficacy of boosters remains unclear. In a cohort of indi-viduals primed with the mRNA-1273 or BNT162b2 vaccines, we report that lower antibody levels before boost are associated with higher fold-increase in antibody levels after boost, suggesting that pre-existing antibody modulates the immunogenicity of mRNA vaccines. Our studies in mice show that pre-existing antibodies accelerate the clearance of vaccine antigen via Fc-dependent mechanisms, limiting the amount of antigen available to prime B cell responses after mRNA boosters. These data demonstrate a "tug of war"between pre-existing antibody responses and de novo B cell responses following mRNA vaccination, and they suggest that transient downmodulation of antibody effector function may improve the efficacy of mRNA boosters.

引用

页数：20

共 50 条

[31] Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient [J].

Bhaumik, Siddhartha K. ;

Priyamvada, Lalita ;

Kauffman, Robert C. ;

Lai, Lilin ;

Natrajan, Muktha S. ;

Cho, Alice ;

Rouphael, Nadine ;

Suthar, Mehul S. ;

Mulligan, Mark J. ;

Wrammert, Jens .

VIRUSES-BASEL, 2019, 11 (01)

[32] Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5 [J].

Abe, Shinya ;

Okuda, Kenji ;

Ura, Takehiro ;

Kondo, Asami ;

Yoshida, Atsushi ;

Yoshizaki, Shinji ;

Mizuguchi, Hiroyuki ;

Klinman, Dennis ;

Shimada, Masaru .

JOURNAL OF GENE MEDICINE, 2009, 11 (07) :570-579

[33] Vaccines Expressing the Innate Immune Modulator EAT-2 Elicit Potent Effector Memory T Lymphocyte Responses despite Pre-Existing Vaccine Immunity [J].

Aldhamen, Yasser Ali ;

Seregin, Sergey S. ;

Schuldt, Nathaniel J. ;

Rastall, David P. W. ;

Liu, Chyong-jy J. ;

Godbehere, Sarah ;

Amalfitano, Andrea .

JOURNAL OF IMMUNOLOGY, 2012, 189 (03) :1349-1359

[34] Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity [J].

Desikan, Rajat ;

Linderman, Susanne L. ;

Davis, Carl ;

Zarnitsyna, Veronika I. ;

Ahmed, Hasan ;

Antia, Rustom .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[35] Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis [J].

Kerschbaumer, Andreas ;

Rivai, Zaida Iasha ;

Smolen, Josef S. ;

Aletaha, Daniel .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10) :1374-1378

[36] Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice [J].

Annoni, Andrea ;

Cantore, Alessio ;

Della Valle, Patrizia ;

Goudy, Kevin ;

Akbarpour, Mahzad ;

Russo, Fabio ;

Bartolaccini, Sara ;

D'Angelo, Armando ;

Roncarolo, Maria Grazia ;

Naldini, Luigi .

EMBO MOLECULAR MEDICINE, 2013, 5 (11) :1684-1697

[37] Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity [J].

Kuether, E. L. ;

Schroeder, J. A. ;

Fahs, S. A. ;

Cooley, B. C. ;

Chen, Y. ;

Montgomery, R. R. ;

Wilcox, D. A. ;

Shi, Q. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) :1570-1580

[38] Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers [J].

Brigitte Gückel ;

Christine Rentzsch ;

Maria-Dorothea Nastke ;

Alexander Marmé ;

Ines Gruber ;

Stefan Stevanović ;

Simone Kayser ;

Diethelm Wallwiener .

Journal of Cancer Research and Clinical Oncology, 2006, 132 :265-274

[39] Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 Vectors [J].

Wang, Lili ;

Calcedo, Roberto ;

Bell, Peter ;

Lin, Jianping ;

Grant, Rebecca L. ;

Siegel, Don L. ;

Wilson, James M. .

HUMAN GENE THERAPY, 2011, 22 (11) :1389-1401

[40] Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers [J].

Gückel, B ;

Rentzsch, C ;

Nastke, MD ;

Marmé, A ;

Gruber, I ;

Stevanovic, S ;

Kayser, S ;

Wallwiener, D .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (04) :265-274

← 1 2 3 4 5 →